-
Mashup Score: 3
Background Chile was severely affected by COVID19 outbreaks but was also one of the first countries to start a nationwide program to vaccinate against the disease. Furthermore, Chile became one of the fastest countries to inoculate a high percentage of the target population and implemented homologous and heterologous booster schemes in late 2021 to prevent potential immunological waning. The aim…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2
Background Binding and neutralising anti-Spike antibodies play a key role in immune defence against SARS-CoV-2 infection. Since it is known that antibodies wane with time and new immune-evasive variants are emerging, we aimed to assess the dynamics of anti-Spike antibodies in an African adult population with prior SARS-CoV-2 infection and to determine the effect of subsequent COVID-19…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#AstraZeneca #COVID19Vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2. @kjambo @MlwTrust @LSTMnews @MarahChibwana Read it here: https://t.co/64Bb2Hw9sz https://t.co/UHE26LkAUg
-
-
Mashup Score: 13 Doses of COVID-19 Vaccine Neutralize the Omicron Variant - 2 year(s) ago
A third dose of the Pfizer-BioNTech or AstraZeneca mRNA COVID-19 vaccines produced sufficient neutralizing antibody titers against the Omicron variant.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
A third dose of the #Pfizer-BioNTech or #AstraZeneca mRNA COVID-19 vaccines produced sufficient neutralizing antibody titers against the #Omicron variant. https://t.co/stKYkxrtow
-
-
Mashup Score: 15Oxford-AstraZeneca COVID-19 vaccine protection wanes after three months, study suggests - 2 year(s) ago
The protection offered by the Oxford-AstraZeneca COVID-19 vaccine declines after three months of receiving two doses, a study says.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Oxford-#AstraZeneca COVID-19 #vaccine protection wanes after three months, study suggests @TheLancet https://t.co/UhmfSVmypt
-
-
Mashup Score: 2FDA authorizes AstraZeneca antibody cocktail for pre-exposure prevention of COVID-19 - 2 year(s) ago
The FDA has for the first time approved an emergency use authorization for a long-acting monoclonal antibody cocktail designed to prevent symptomatic COVID-19 among adults and children aged 12 years and older. According to data submitted to the FDA, AstraZeneca’s Evusheld (tixagevimab plus cilgavimab), also known as AZD7442, when sued The pre-exposure prophylaxis, can reduce the risk for
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
The #FDA has approved an emergency use authorization for #AstraZeneca's long-acting monoclonal antibody cocktail designed to prevent symptomatic #COVID19 in adults and children aged 12 years and older. Comments from @alhkim, perspective from @LCalabreseDO https://t.co/lJP8dYaOGb
-
-
Mashup Score: 155
All study vaccines boosted antibody and neutralising responses after ChAd/ChAd initial course and all except one after BNT/BNT, with no safety concerns. Substantial differences in humoral and cellular responses, and vaccine availability will influence policy choices for booster vaccination.
Source: The LancetCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
NEW—Six different COVID-19 boosters are safe and increase immunity when given after two doses of #AstraZeneca or #Pfizer-BioNTech, with large variations in immune responses, UK trial shows. https://t.co/ktUp1m2Rsb https://t.co/wlwxcLYDm1
-
-
Mashup Score: 21
Fears of adverse effects of COVID-19 vaccination on fertility have affected vaccine uptake in some communities. Despite the absence of supporting evidence for such a risk, low biological plausibility, and preliminary data supporting the safety of mRNA vaccines in pregnancy,1–3 this claim has become widespread, and it has been challenged by WHO.4 Vaccine hesitancy during pregnancy, or among women…
Source: The LancetCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
New research letter: Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Authors analysed pregnancies occurring in four ongoing clinical trials in the UK, Brazil, and South Africa. https://t.co/hDM1olKts9 @OxfordVacGroup | #COVID19 #AstraZeneca https://t.co/m5qvWhPcph
-
-
Mashup Score: 1
The drug reduced the risk of severe COVID-19 or death by 50% in non-hospitalized patients who have had symptoms for seven days or less.
Source: www.mdedge.comCategories: Latest Headlines, PediatricsTweet-
#AstraZeneca’s new drug, a combination of 2 #antibodies called AZD7442, reduced the risk of severe COVID-19 or death by 50% in non-hospitalized patients who have had symptoms for 7 days or less, according to a company statement. https://t.co/sVFf8d3njg https://t.co/QinHURaxQn
-
-
Mashup Score: 0
In the recent TACKLE phase 3 trial, AZD7442 significantly reduced the risk of developing severe COVID-19 or death, even among high-risk populations.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI #AstraZeneca had successful phase 3 trials for #AZD7442, the first long-acting antibody combination for #COVID19 prophylaxis and treatment. #AZD7442 was proven to reduce the risk of severe or fatal #COVID19, even among high-risk populations. https://t.co/GVKUnwYqMJ
-
-
Mashup Score: 0What We’re Reading: Anxiety, Depression Rates in Pandemic; Major Insurers Behind on Billions Owed; AstraZeneca Pays in Discrimination Settlement - 3 year(s) ago
Anxiety and depression rates increased 13% and 14.8%, respectively, in 2020, before declining in 2021; Anthem Blue Cross and UnitedHealthcare are among major insurers behind on payments; a federal investigation discovered racial and gender-based pay discrimination among sales representatives at AstraZeneca.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
What We’re Reading: Anxiety, Depression Rates in Pandemic; Major Insurers Behind on Billions Owed; #AstraZeneca Pays in Discrimination Settlement https://t.co/XLRvP0fZrw https://t.co/quZOAgETUD
-
Two-dose #Sinovac induced ↓ levels of anti-SARS-CoV-2 spike antibodies vs #Pfizer - heterologous #booster with #Pfizer or #AstraZeneca potentiated ↑ response induced by #Sinovac Chile's #COVIDvaccine experience reported by @uchile @Fbosorioo @BonoRosa - https://t.co/EtkI4jVSLq https://t.co/PzdDZNz7Tv